Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (MAW) - Phase 3 Pilot Clinical Trial

NCT02431611 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02431611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (MAW) - Phase 3 Pilot Clinical Trial
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
December 31, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, pregnancy